Skip to content

Actual situation of the treatment in patients with dry eye disease using Japanese claims data.

Actual situation of the treatment in patients with dry eye disease using Japanese claims data. - Actual situation of the treatment in patients with dry eye disease using Japanese claims data.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000056510
Enrollment
400000
Registered
2024-12-20
Start date
2024-12-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye disease

Interventions

None listed

Sponsors

Viatris Pharmaceuticals Japan G.K.
Lead Sponsor
Japan Dry Eye Society
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who had any of the dry eye disease or sjogren syndrome (ICD-10 codes H041, M350) .

Exclusion criteria

Exclusion criteria: Patients who meet any of the following criteria are excluded from the analysis. Patients who had a treatment history for dry eye disease on-label treatment within 36 months before the cohort entry month. Patients who did not have at least 36 months of continuous enrollment in the database before the cohort entry month

Design outcomes

Primary

MeasureTime frame
There are no outcomes because this is an exploratory research

Countries

Japan

Contacts

Public ContactShota Uchino

DATACK Inc. Real World Data Research Strategy Division

kanri@datack.jp03-6775-4814

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026